Clinomic successfully closes a financing round of 16 million euros

Clinomic strengthens its position in the medical technology sector: with a successfully completed financing round of 16 million euros, the company is focusing on digital healthcare solutions

Aachen - The medical technology company Clinomic, based in Aachen, Germany, successfully completed a financing round in July 2023. In addition to existing shareholders, Sana Kliniken AG and a family office also provided funds in this round. The capital raised will flow into the further growth strategy and the development of new products.

Clinomic Group GmbH, based in Aachen, Germany, closed a financing round of around 16 million euros in July 2023. This was made possible by issuing new shares and converting existing loans into equity. The already invested shareholders participated again in the financing and two new investors joined the shareholder group: Sana Kliniken AG and a family office from Luxembourg. Both will hold minority shares in Clinomic.

Technological progress is of great importance for the healthcare industry, especially for Sana. That is why we support innovative companies like Clinomic. Together we are shaping the intensive care unit of the future!

Thomas Lemke, CEO of Sana Kliniken AG

The funds raised will be used to accelerate digitalization in the healthcare sector and optimize processes in intensive and acute care medicine. The management of Sana Kliniken AG views the investment positively.

The fresh funding will enable Clinomic to further develop its approaches to improve medical care and patient care. Particularly in the area of intensive and acute medical care, the company aims to optimize processes and increase efficiency through technological solutions.

Our aim was to rethink intensive care medicine and radically simplify everyday life in the intensive care unit

Dr. med. Lukas Martin, founder and CMO Priv.-Doz.

The participation of Sana Kliniken AG and the Luxembourg Family Office in this financing round reflects the confidence in Clinomic's strategic direction. The company is now well positioned to achieve its development goals and make a positive contribution to the further development of the healthcare sector.

We already reported on Clinomic's digital assistant Mona in 2021. If you would like to develop a deeper understanding of the startup's approach, we highly recommend reading the article. Founded in 2019 as a spin-off from RWTH Aachen University, Clinomic is an up-and-coming medical technology start-up from Aachen. Under the leadership of founders Dr. Arne Peine and Dr. Lukas Martin, the interdisciplinary team has developed Mona, an innovative, voice-controlled assistance system for intensive care medicine. This system aims to revolutionize the treatment of critically ill patients by using state-of-the-art medical research and AI algorithms. The solution supports doctors and medical staff in making precise decisions, providing evidence-based treatment and making efficient use of resources directly at the patient's bedside. Clinomic 2022 has taken a significant step in its development by launching the Clinomic Group to drive the digital transformation of the hospital and actively contribute to shaping an intelligent, efficient and resource-oriented healthcare system.